Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence of Pliva terbinafine 1% cream vs Lamisil in uncomplicated tinea pedis
2006-000775-15Phase 3Completed
- Sponsor
- PLIVA
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Terbinafine in Athlete's foot (3 arms), sponsored by PLIVA. Primary endpoint: Negative mycology culture at visit 3. Started Aug 2006; status: completed.
02
Drugs
Terbinafine
03
Conditions
Athlete's foot
Beyond the preview
Go deeper on 2006-000775-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000775-15.